Key Insights
The global Montelukast Sodium market, valued at $4.08 billion in 2025, is projected to experience robust growth, driven by a Compound Annual Growth Rate (CAGR) of 12.60% from 2025 to 2033. This expansion is fueled by several key factors. The rising prevalence of respiratory diseases like asthma and allergic rhinitis, particularly in developing nations, is a primary driver. Increasing awareness of these conditions and improved access to healthcare are contributing to higher diagnosis rates and subsequent medication demand. Furthermore, the effectiveness and relative safety profile of Montelukast Sodium compared to other treatment options, such as corticosteroids, position it favorably within the market. Generic competition is impacting pricing, yet the overall market volume continues to grow due to expanded patient access. The market is segmented by dosage form (tablets and oral solutions) and application (Asthma, Allergic Rhinitis, Urticaria, and other applications). Tablets currently dominate the market share, however, the oral solution segment is anticipated to show faster growth due to ease of administration, particularly for pediatric patients. North America and Europe currently hold significant market shares, reflecting higher healthcare expenditure and established healthcare infrastructure. However, rapidly developing economies in Asia-Pacific, particularly India and China, are poised for substantial growth, fueled by increasing disposable incomes and rising healthcare awareness. This presents significant opportunities for market expansion in the coming years. Competition among established pharmaceutical companies like Merck & Co Inc, Sanofi Aventis SA, and Cipla Limited, alongside emerging players, is intensifying, leading to innovations in formulations and delivery systems.
The future of the Montelukast Sodium market is promising, with continued growth anticipated throughout the forecast period. However, potential market restraints include the emergence of biosimilar competition, the development of novel therapeutic alternatives, and price pressure from generic manufacturers. Regulatory hurdles and variations in healthcare policies across different regions could also influence market trajectory. Nevertheless, the persistent prevalence of respiratory illnesses, coupled with ongoing research and development efforts aimed at improving treatment efficacy and patient compliance, are expected to sustain market momentum. Strategic partnerships, mergers and acquisitions, and the introduction of innovative formulations will likely shape the competitive landscape in the years to come. A focus on improving access to Montelukast Sodium in underserved populations will be crucial for maximizing market potential and improving global respiratory health.

Montelukast Sodium Market Report: A Comprehensive Analysis (2019-2033)
This comprehensive report provides a detailed analysis of the global Montelukast Sodium market, encompassing market dynamics, growth trends, regional dominance, product landscape, and key player activities. The report covers the historical period (2019-2024), base year (2025), and forecast period (2025-2033), offering invaluable insights for industry professionals, investors, and strategic decision-makers. The parent market is the Anti-allergic drugs market and the child market is the Leukotriene Receptor Antagonists Market. This report projects a market value of xx Million units by 2033.
Montelukast Sodium Market Dynamics & Structure
This section analyzes the competitive landscape of the Montelukast Sodium market, examining factors influencing its structure and evolution. The market is characterized by a moderate level of concentration, with key players holding significant market share, though smaller players also contribute. Technological innovation is a key driver, with ongoing research focusing on improved formulations and delivery systems. Regulatory frameworks, varying across different regions, significantly impact market access and product approval timelines. The presence of competitive substitute drugs necessitates ongoing product differentiation and value-added service strategies. End-user demographics, including prevalence rates of asthma and allergic rhinitis, strongly influence market demand. Finally, M&A activity in the pharmaceutical industry plays a role, impacting market consolidation and competitive dynamics.
- Market Concentration: Moderate, with top 5 players holding approximately xx% market share in 2024.
- Technological Innovation: Focus on improved bioavailability, targeted drug delivery, and combination therapies.
- Regulatory Frameworks: Varying approval processes and pricing regulations across regions.
- Competitive Substitutes: Presence of other anti-asthma and anti-allergic medications.
- End-User Demographics: Growing prevalence of asthma and allergic rhinitis drives market demand.
- M&A Trends: Moderate level of consolidation through acquisitions and partnerships. xx M&A deals in the Leukotriene Receptor Antagonists market were recorded between 2019-2024.
Montelukast Sodium Market Growth Trends & Insights
The Montelukast Sodium market has experienced steady growth over the past few years, driven by increasing prevalence of respiratory illnesses, rising healthcare expenditure, and growing awareness about allergy management. The market size experienced a CAGR of xx% during the historical period (2019-2024), reaching xx Million units in 2024. This growth is expected to continue, albeit at a slightly moderated pace, throughout the forecast period (2025-2033), with a projected CAGR of xx%, reaching xx Million units by 2033. This growth is underpinned by factors such as increasing healthcare awareness, improved diagnosis rates, and the introduction of newer, more effective formulations. Technological advancements, including innovative drug delivery systems, are contributing to increased market penetration. Changing consumer preferences, with a shift toward convenient and more effective treatments, further fuel market expansion.

Dominant Regions, Countries, or Segments in Montelukast Sodium Market
North America currently dominates the Montelukast Sodium market, driven by high healthcare expenditure, high prevalence of asthma and allergic rhinitis, and robust regulatory frameworks. However, Asia-Pacific is expected to exhibit the fastest growth rate over the forecast period.
- By Dosage Form: Tablets currently hold the largest market share due to their convenience and ease of administration. Oral solutions are expected to witness moderate growth.
- By Application: Asthma is the leading application segment, followed by allergic rhinitis. Urticaria and other applications represent smaller but growing segments.
- Key Drivers (North America): High healthcare expenditure, well-established healthcare infrastructure, and high awareness about respiratory health.
- Key Drivers (Asia-Pacific): Rising prevalence of respiratory illnesses, increasing disposable incomes, and expanding healthcare infrastructure.
Montelukast Sodium Market Product Landscape
The Montelukast Sodium market offers a range of formulations, including tablets and oral solutions, catering to diverse patient needs and preferences. Recent innovations focus on improving bioavailability, enhancing patient compliance, and providing targeted drug delivery. Unique selling propositions include sustained-release formulations, reduced side-effect profiles, and convenient dosage forms. Technological advancements like improved manufacturing processes and innovative drug delivery systems contribute to product differentiation.
Key Drivers, Barriers & Challenges in Montelukast Sodium Market
Key Drivers: The rising prevalence of asthma and allergic rhinitis globally is a primary driver, alongside increasing healthcare expenditure and greater awareness regarding respiratory health management. Government initiatives promoting early diagnosis and treatment further contribute to market expansion.
Key Challenges: Intense competition from generic and biosimilar drugs and stringent regulatory approvals pose significant challenges. Supply chain disruptions and price pressures from generics also limit profitability. The potential for side effects and drug interactions also act as restraints. The impact of these factors on market growth is estimated to be xx% in the forecast period.
Emerging Opportunities in Montelukast Sodium Market
Untapped markets in developing economies, coupled with the potential for combination therapies targeting multiple respiratory conditions, present substantial growth opportunities. The increasing prevalence of allergies among children offers further expansion possibilities, particularly for pediatric formulations. Developing novel drug delivery systems to improve patient compliance and reduce side effects is another promising area.
Growth Accelerators in the Montelukast Sodium Market Industry
Strategic partnerships, focusing on market access and distribution in new regions, are accelerating market growth. Technological breakthroughs, particularly in drug delivery systems and formulation development, improve efficacy and patient compliance. Expansion into untapped markets and the development of novel formulations addressing unmet clinical needs are also key drivers.
Key Players Shaping the Montelukast Sodium Market Market
- Sanyo Chemical Industries Ltd
- Merck & Co Inc (Merck & Co Inc)
- SK Capital (Apotex Inc)
- Sanofi Aventis SA (Sanofi Aventis SA)
- Morepen Laboratories
- Teva Pharmaceuticals USA Inc (Teva Pharmaceuticals USA Inc)
- Delmar Chemicals Inc
- Cipla Limited (Cipla Limited)
- SUN PHARMA (SUN PHARMA)
- Intas Pharmaceuticals Ltd
Notable Milestones in Montelukast Sodium Market Sector
- December 2021: Morepen Laboratories receives US FDA approval for generic Fexofenadine Hydrochloride, increasing competition in the anti-allergy market.
- March 2021: Valeo Pharma secures a commercialization agreement with Novartis for asthma therapies in Canada, expanding market access for these treatments.
In-Depth Montelukast Sodium Market Market Outlook
The Montelukast Sodium market is poised for continued growth, driven by the factors discussed above. Strategic investments in research and development, focusing on innovative formulations and improved drug delivery systems, will shape the future market landscape. Expansion into new markets and strategic collaborations will further enhance market potential, creating lucrative opportunities for key players. The market is expected to witness significant value expansion in the coming years, with the potential for substantial growth in specific regional markets and application segments.
Montelukast Sodium Market Segmentation
-
1. Dosage Form
- 1.1. Tablets
- 1.2. Oral Solutions
-
2. Application
- 2.1. Asthma
- 2.2. Allergic Rhinitis
- 2.3. Urticaria
- 2.4. Other Applications
Montelukast Sodium Market Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. Europe
- 2.1. Germany
- 2.2. United Kingdom
- 2.3. France
- 2.4. Italy
- 2.5. Spain
- 2.6. Rest of Europe
-
3. Asia Pacific
- 3.1. China
- 3.2. Japan
- 3.3. India
- 3.4. Australia
- 3.5. South Korea
- 3.6. Rest of Asia Pacific
- 4. Rest of the World

Montelukast Sodium Market REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 12.60% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1 Increasing Prevalence of Disease like Asthma
- 3.2.2 Allergic Rhinitis
- 3.2.3 etc.; Rise in Geriatric Population
- 3.3. Market Restrains
- 3.3.1. Side Effects of the Product
- 3.4. Market Trends
- 3.4.1. Asthma Segment is Expected to be Hold Significant Share in the Montelukast Sodium Market
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Montelukast Sodium Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Dosage Form
- 5.1.1. Tablets
- 5.1.2. Oral Solutions
- 5.2. Market Analysis, Insights and Forecast - by Application
- 5.2.1. Asthma
- 5.2.2. Allergic Rhinitis
- 5.2.3. Urticaria
- 5.2.4. Other Applications
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. Asia Pacific
- 5.3.4. Rest of the World
- 5.1. Market Analysis, Insights and Forecast - by Dosage Form
- 6. North America Montelukast Sodium Market Analysis, Insights and Forecast, 2019-2031
- 6.1. Market Analysis, Insights and Forecast - by Dosage Form
- 6.1.1. Tablets
- 6.1.2. Oral Solutions
- 6.2. Market Analysis, Insights and Forecast - by Application
- 6.2.1. Asthma
- 6.2.2. Allergic Rhinitis
- 6.2.3. Urticaria
- 6.2.4. Other Applications
- 6.1. Market Analysis, Insights and Forecast - by Dosage Form
- 7. Europe Montelukast Sodium Market Analysis, Insights and Forecast, 2019-2031
- 7.1. Market Analysis, Insights and Forecast - by Dosage Form
- 7.1.1. Tablets
- 7.1.2. Oral Solutions
- 7.2. Market Analysis, Insights and Forecast - by Application
- 7.2.1. Asthma
- 7.2.2. Allergic Rhinitis
- 7.2.3. Urticaria
- 7.2.4. Other Applications
- 7.1. Market Analysis, Insights and Forecast - by Dosage Form
- 8. Asia Pacific Montelukast Sodium Market Analysis, Insights and Forecast, 2019-2031
- 8.1. Market Analysis, Insights and Forecast - by Dosage Form
- 8.1.1. Tablets
- 8.1.2. Oral Solutions
- 8.2. Market Analysis, Insights and Forecast - by Application
- 8.2.1. Asthma
- 8.2.2. Allergic Rhinitis
- 8.2.3. Urticaria
- 8.2.4. Other Applications
- 8.1. Market Analysis, Insights and Forecast - by Dosage Form
- 9. Rest of the World Montelukast Sodium Market Analysis, Insights and Forecast, 2019-2031
- 9.1. Market Analysis, Insights and Forecast - by Dosage Form
- 9.1.1. Tablets
- 9.1.2. Oral Solutions
- 9.2. Market Analysis, Insights and Forecast - by Application
- 9.2.1. Asthma
- 9.2.2. Allergic Rhinitis
- 9.2.3. Urticaria
- 9.2.4. Other Applications
- 9.1. Market Analysis, Insights and Forecast - by Dosage Form
- 10. North America Montelukast Sodium Market Analysis, Insights and Forecast, 2019-2031
- 10.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 10.1.1 United States
- 10.1.2 Canada
- 10.1.3 Mexico
- 11. Europe Montelukast Sodium Market Analysis, Insights and Forecast, 2019-2031
- 11.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 11.1.1 Germany
- 11.1.2 United Kingdom
- 11.1.3 France
- 11.1.4 Spain
- 11.1.5 Italy
- 11.1.6 Spain
- 11.1.7 Belgium
- 11.1.8 Netherland
- 11.1.9 Nordics
- 11.1.10 Rest of Europe
- 12. Asia Pacific Montelukast Sodium Market Analysis, Insights and Forecast, 2019-2031
- 12.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 12.1.1 China
- 12.1.2 Japan
- 12.1.3 India
- 12.1.4 South Korea
- 12.1.5 Southeast Asia
- 12.1.6 Australia
- 12.1.7 Indonesia
- 12.1.8 Phillipes
- 12.1.9 Singapore
- 12.1.10 Thailandc
- 12.1.11 Rest of Asia Pacific
- 13. South America Montelukast Sodium Market Analysis, Insights and Forecast, 2019-2031
- 13.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 13.1.1 Brazil
- 13.1.2 Argentina
- 13.1.3 Peru
- 13.1.4 Chile
- 13.1.5 Colombia
- 13.1.6 Ecuador
- 13.1.7 Venezuela
- 13.1.8 Rest of South America
- 14. North America Montelukast Sodium Market Analysis, Insights and Forecast, 2019-2031
- 14.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 14.1.1 United States
- 14.1.2 Canada
- 14.1.3 Mexico
- 15. MEA Montelukast Sodium Market Analysis, Insights and Forecast, 2019-2031
- 15.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 15.1.1 United Arab Emirates
- 15.1.2 Saudi Arabia
- 15.1.3 South Africa
- 15.1.4 Rest of Middle East and Africa
- 16. Competitive Analysis
- 16.1. Global Market Share Analysis 2024
- 16.2. Company Profiles
- 16.2.1 Sanyo Chemical Industries Ltd
- 16.2.1.1. Overview
- 16.2.1.2. Products
- 16.2.1.3. SWOT Analysis
- 16.2.1.4. Recent Developments
- 16.2.1.5. Financials (Based on Availability)
- 16.2.2 Merck & Co Inc
- 16.2.2.1. Overview
- 16.2.2.2. Products
- 16.2.2.3. SWOT Analysis
- 16.2.2.4. Recent Developments
- 16.2.2.5. Financials (Based on Availability)
- 16.2.3 SK Capital (Apotex Inc)
- 16.2.3.1. Overview
- 16.2.3.2. Products
- 16.2.3.3. SWOT Analysis
- 16.2.3.4. Recent Developments
- 16.2.3.5. Financials (Based on Availability)
- 16.2.4 Sanofi Aventis SA
- 16.2.4.1. Overview
- 16.2.4.2. Products
- 16.2.4.3. SWOT Analysis
- 16.2.4.4. Recent Developments
- 16.2.4.5. Financials (Based on Availability)
- 16.2.5 Morepen Laboratories
- 16.2.5.1. Overview
- 16.2.5.2. Products
- 16.2.5.3. SWOT Analysis
- 16.2.5.4. Recent Developments
- 16.2.5.5. Financials (Based on Availability)
- 16.2.6 Teva Pharmaceuticals USA Inc
- 16.2.6.1. Overview
- 16.2.6.2. Products
- 16.2.6.3. SWOT Analysis
- 16.2.6.4. Recent Developments
- 16.2.6.5. Financials (Based on Availability)
- 16.2.7 Delmar Chemicals Inc
- 16.2.7.1. Overview
- 16.2.7.2. Products
- 16.2.7.3. SWOT Analysis
- 16.2.7.4. Recent Developments
- 16.2.7.5. Financials (Based on Availability)
- 16.2.8 Cipla Limited
- 16.2.8.1. Overview
- 16.2.8.2. Products
- 16.2.8.3. SWOT Analysis
- 16.2.8.4. Recent Developments
- 16.2.8.5. Financials (Based on Availability)
- 16.2.9 SUN PHARMA
- 16.2.9.1. Overview
- 16.2.9.2. Products
- 16.2.9.3. SWOT Analysis
- 16.2.9.4. Recent Developments
- 16.2.9.5. Financials (Based on Availability)
- 16.2.10 Intas Pharmaceuticals Ltd
- 16.2.10.1. Overview
- 16.2.10.2. Products
- 16.2.10.3. SWOT Analysis
- 16.2.10.4. Recent Developments
- 16.2.10.5. Financials (Based on Availability)
- 16.2.1 Sanyo Chemical Industries Ltd
List of Figures
- Figure 1: Global Montelukast Sodium Market Revenue Breakdown (Million, %) by Region 2024 & 2032
- Figure 2: Global Montelukast Sodium Market Volume Breakdown (K Unit, %) by Region 2024 & 2032
- Figure 3: North America Montelukast Sodium Market Revenue (Million), by Country 2024 & 2032
- Figure 4: North America Montelukast Sodium Market Volume (K Unit), by Country 2024 & 2032
- Figure 5: North America Montelukast Sodium Market Revenue Share (%), by Country 2024 & 2032
- Figure 6: North America Montelukast Sodium Market Volume Share (%), by Country 2024 & 2032
- Figure 7: Europe Montelukast Sodium Market Revenue (Million), by Country 2024 & 2032
- Figure 8: Europe Montelukast Sodium Market Volume (K Unit), by Country 2024 & 2032
- Figure 9: Europe Montelukast Sodium Market Revenue Share (%), by Country 2024 & 2032
- Figure 10: Europe Montelukast Sodium Market Volume Share (%), by Country 2024 & 2032
- Figure 11: Asia Pacific Montelukast Sodium Market Revenue (Million), by Country 2024 & 2032
- Figure 12: Asia Pacific Montelukast Sodium Market Volume (K Unit), by Country 2024 & 2032
- Figure 13: Asia Pacific Montelukast Sodium Market Revenue Share (%), by Country 2024 & 2032
- Figure 14: Asia Pacific Montelukast Sodium Market Volume Share (%), by Country 2024 & 2032
- Figure 15: South America Montelukast Sodium Market Revenue (Million), by Country 2024 & 2032
- Figure 16: South America Montelukast Sodium Market Volume (K Unit), by Country 2024 & 2032
- Figure 17: South America Montelukast Sodium Market Revenue Share (%), by Country 2024 & 2032
- Figure 18: South America Montelukast Sodium Market Volume Share (%), by Country 2024 & 2032
- Figure 19: North America Montelukast Sodium Market Revenue (Million), by Country 2024 & 2032
- Figure 20: North America Montelukast Sodium Market Volume (K Unit), by Country 2024 & 2032
- Figure 21: North America Montelukast Sodium Market Revenue Share (%), by Country 2024 & 2032
- Figure 22: North America Montelukast Sodium Market Volume Share (%), by Country 2024 & 2032
- Figure 23: MEA Montelukast Sodium Market Revenue (Million), by Country 2024 & 2032
- Figure 24: MEA Montelukast Sodium Market Volume (K Unit), by Country 2024 & 2032
- Figure 25: MEA Montelukast Sodium Market Revenue Share (%), by Country 2024 & 2032
- Figure 26: MEA Montelukast Sodium Market Volume Share (%), by Country 2024 & 2032
- Figure 27: North America Montelukast Sodium Market Revenue (Million), by Dosage Form 2024 & 2032
- Figure 28: North America Montelukast Sodium Market Volume (K Unit), by Dosage Form 2024 & 2032
- Figure 29: North America Montelukast Sodium Market Revenue Share (%), by Dosage Form 2024 & 2032
- Figure 30: North America Montelukast Sodium Market Volume Share (%), by Dosage Form 2024 & 2032
- Figure 31: North America Montelukast Sodium Market Revenue (Million), by Application 2024 & 2032
- Figure 32: North America Montelukast Sodium Market Volume (K Unit), by Application 2024 & 2032
- Figure 33: North America Montelukast Sodium Market Revenue Share (%), by Application 2024 & 2032
- Figure 34: North America Montelukast Sodium Market Volume Share (%), by Application 2024 & 2032
- Figure 35: North America Montelukast Sodium Market Revenue (Million), by Country 2024 & 2032
- Figure 36: North America Montelukast Sodium Market Volume (K Unit), by Country 2024 & 2032
- Figure 37: North America Montelukast Sodium Market Revenue Share (%), by Country 2024 & 2032
- Figure 38: North America Montelukast Sodium Market Volume Share (%), by Country 2024 & 2032
- Figure 39: Europe Montelukast Sodium Market Revenue (Million), by Dosage Form 2024 & 2032
- Figure 40: Europe Montelukast Sodium Market Volume (K Unit), by Dosage Form 2024 & 2032
- Figure 41: Europe Montelukast Sodium Market Revenue Share (%), by Dosage Form 2024 & 2032
- Figure 42: Europe Montelukast Sodium Market Volume Share (%), by Dosage Form 2024 & 2032
- Figure 43: Europe Montelukast Sodium Market Revenue (Million), by Application 2024 & 2032
- Figure 44: Europe Montelukast Sodium Market Volume (K Unit), by Application 2024 & 2032
- Figure 45: Europe Montelukast Sodium Market Revenue Share (%), by Application 2024 & 2032
- Figure 46: Europe Montelukast Sodium Market Volume Share (%), by Application 2024 & 2032
- Figure 47: Europe Montelukast Sodium Market Revenue (Million), by Country 2024 & 2032
- Figure 48: Europe Montelukast Sodium Market Volume (K Unit), by Country 2024 & 2032
- Figure 49: Europe Montelukast Sodium Market Revenue Share (%), by Country 2024 & 2032
- Figure 50: Europe Montelukast Sodium Market Volume Share (%), by Country 2024 & 2032
- Figure 51: Asia Pacific Montelukast Sodium Market Revenue (Million), by Dosage Form 2024 & 2032
- Figure 52: Asia Pacific Montelukast Sodium Market Volume (K Unit), by Dosage Form 2024 & 2032
- Figure 53: Asia Pacific Montelukast Sodium Market Revenue Share (%), by Dosage Form 2024 & 2032
- Figure 54: Asia Pacific Montelukast Sodium Market Volume Share (%), by Dosage Form 2024 & 2032
- Figure 55: Asia Pacific Montelukast Sodium Market Revenue (Million), by Application 2024 & 2032
- Figure 56: Asia Pacific Montelukast Sodium Market Volume (K Unit), by Application 2024 & 2032
- Figure 57: Asia Pacific Montelukast Sodium Market Revenue Share (%), by Application 2024 & 2032
- Figure 58: Asia Pacific Montelukast Sodium Market Volume Share (%), by Application 2024 & 2032
- Figure 59: Asia Pacific Montelukast Sodium Market Revenue (Million), by Country 2024 & 2032
- Figure 60: Asia Pacific Montelukast Sodium Market Volume (K Unit), by Country 2024 & 2032
- Figure 61: Asia Pacific Montelukast Sodium Market Revenue Share (%), by Country 2024 & 2032
- Figure 62: Asia Pacific Montelukast Sodium Market Volume Share (%), by Country 2024 & 2032
- Figure 63: Rest of the World Montelukast Sodium Market Revenue (Million), by Dosage Form 2024 & 2032
- Figure 64: Rest of the World Montelukast Sodium Market Volume (K Unit), by Dosage Form 2024 & 2032
- Figure 65: Rest of the World Montelukast Sodium Market Revenue Share (%), by Dosage Form 2024 & 2032
- Figure 66: Rest of the World Montelukast Sodium Market Volume Share (%), by Dosage Form 2024 & 2032
- Figure 67: Rest of the World Montelukast Sodium Market Revenue (Million), by Application 2024 & 2032
- Figure 68: Rest of the World Montelukast Sodium Market Volume (K Unit), by Application 2024 & 2032
- Figure 69: Rest of the World Montelukast Sodium Market Revenue Share (%), by Application 2024 & 2032
- Figure 70: Rest of the World Montelukast Sodium Market Volume Share (%), by Application 2024 & 2032
- Figure 71: Rest of the World Montelukast Sodium Market Revenue (Million), by Country 2024 & 2032
- Figure 72: Rest of the World Montelukast Sodium Market Volume (K Unit), by Country 2024 & 2032
- Figure 73: Rest of the World Montelukast Sodium Market Revenue Share (%), by Country 2024 & 2032
- Figure 74: Rest of the World Montelukast Sodium Market Volume Share (%), by Country 2024 & 2032
List of Tables
- Table 1: Global Montelukast Sodium Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Global Montelukast Sodium Market Volume K Unit Forecast, by Region 2019 & 2032
- Table 3: Global Montelukast Sodium Market Revenue Million Forecast, by Dosage Form 2019 & 2032
- Table 4: Global Montelukast Sodium Market Volume K Unit Forecast, by Dosage Form 2019 & 2032
- Table 5: Global Montelukast Sodium Market Revenue Million Forecast, by Application 2019 & 2032
- Table 6: Global Montelukast Sodium Market Volume K Unit Forecast, by Application 2019 & 2032
- Table 7: Global Montelukast Sodium Market Revenue Million Forecast, by Region 2019 & 2032
- Table 8: Global Montelukast Sodium Market Volume K Unit Forecast, by Region 2019 & 2032
- Table 9: Global Montelukast Sodium Market Revenue Million Forecast, by Country 2019 & 2032
- Table 10: Global Montelukast Sodium Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 11: United States Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 12: United States Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 13: Canada Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 14: Canada Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 15: Mexico Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 16: Mexico Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 17: Global Montelukast Sodium Market Revenue Million Forecast, by Country 2019 & 2032
- Table 18: Global Montelukast Sodium Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 19: Germany Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 20: Germany Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 21: United Kingdom Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 22: United Kingdom Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 23: France Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 24: France Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 25: Spain Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 26: Spain Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 27: Italy Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 28: Italy Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 29: Spain Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 30: Spain Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 31: Belgium Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 32: Belgium Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 33: Netherland Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 34: Netherland Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 35: Nordics Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 36: Nordics Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 37: Rest of Europe Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 38: Rest of Europe Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 39: Global Montelukast Sodium Market Revenue Million Forecast, by Country 2019 & 2032
- Table 40: Global Montelukast Sodium Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 41: China Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 42: China Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 43: Japan Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 44: Japan Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 45: India Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 46: India Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 47: South Korea Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 48: South Korea Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 49: Southeast Asia Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 50: Southeast Asia Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 51: Australia Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 52: Australia Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 53: Indonesia Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 54: Indonesia Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 55: Phillipes Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 56: Phillipes Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 57: Singapore Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 58: Singapore Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 59: Thailandc Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 60: Thailandc Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 61: Rest of Asia Pacific Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 62: Rest of Asia Pacific Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 63: Global Montelukast Sodium Market Revenue Million Forecast, by Country 2019 & 2032
- Table 64: Global Montelukast Sodium Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 65: Brazil Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 66: Brazil Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 67: Argentina Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 68: Argentina Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 69: Peru Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 70: Peru Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 71: Chile Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 72: Chile Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 73: Colombia Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 74: Colombia Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 75: Ecuador Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 76: Ecuador Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 77: Venezuela Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 78: Venezuela Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 79: Rest of South America Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 80: Rest of South America Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 81: Global Montelukast Sodium Market Revenue Million Forecast, by Country 2019 & 2032
- Table 82: Global Montelukast Sodium Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 83: United States Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 84: United States Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 85: Canada Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 86: Canada Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 87: Mexico Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 88: Mexico Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 89: Global Montelukast Sodium Market Revenue Million Forecast, by Country 2019 & 2032
- Table 90: Global Montelukast Sodium Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 91: United Arab Emirates Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 92: United Arab Emirates Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 93: Saudi Arabia Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 94: Saudi Arabia Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 95: South Africa Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 96: South Africa Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 97: Rest of Middle East and Africa Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 98: Rest of Middle East and Africa Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 99: Global Montelukast Sodium Market Revenue Million Forecast, by Dosage Form 2019 & 2032
- Table 100: Global Montelukast Sodium Market Volume K Unit Forecast, by Dosage Form 2019 & 2032
- Table 101: Global Montelukast Sodium Market Revenue Million Forecast, by Application 2019 & 2032
- Table 102: Global Montelukast Sodium Market Volume K Unit Forecast, by Application 2019 & 2032
- Table 103: Global Montelukast Sodium Market Revenue Million Forecast, by Country 2019 & 2032
- Table 104: Global Montelukast Sodium Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 105: United States Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 106: United States Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 107: Canada Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 108: Canada Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 109: Mexico Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 110: Mexico Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 111: Global Montelukast Sodium Market Revenue Million Forecast, by Dosage Form 2019 & 2032
- Table 112: Global Montelukast Sodium Market Volume K Unit Forecast, by Dosage Form 2019 & 2032
- Table 113: Global Montelukast Sodium Market Revenue Million Forecast, by Application 2019 & 2032
- Table 114: Global Montelukast Sodium Market Volume K Unit Forecast, by Application 2019 & 2032
- Table 115: Global Montelukast Sodium Market Revenue Million Forecast, by Country 2019 & 2032
- Table 116: Global Montelukast Sodium Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 117: Germany Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 118: Germany Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 119: United Kingdom Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 120: United Kingdom Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 121: France Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 122: France Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 123: Italy Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 124: Italy Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 125: Spain Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 126: Spain Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 127: Rest of Europe Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 128: Rest of Europe Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 129: Global Montelukast Sodium Market Revenue Million Forecast, by Dosage Form 2019 & 2032
- Table 130: Global Montelukast Sodium Market Volume K Unit Forecast, by Dosage Form 2019 & 2032
- Table 131: Global Montelukast Sodium Market Revenue Million Forecast, by Application 2019 & 2032
- Table 132: Global Montelukast Sodium Market Volume K Unit Forecast, by Application 2019 & 2032
- Table 133: Global Montelukast Sodium Market Revenue Million Forecast, by Country 2019 & 2032
- Table 134: Global Montelukast Sodium Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 135: China Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 136: China Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 137: Japan Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 138: Japan Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 139: India Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 140: India Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 141: Australia Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 142: Australia Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 143: South Korea Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 144: South Korea Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 145: Rest of Asia Pacific Montelukast Sodium Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 146: Rest of Asia Pacific Montelukast Sodium Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 147: Global Montelukast Sodium Market Revenue Million Forecast, by Dosage Form 2019 & 2032
- Table 148: Global Montelukast Sodium Market Volume K Unit Forecast, by Dosage Form 2019 & 2032
- Table 149: Global Montelukast Sodium Market Revenue Million Forecast, by Application 2019 & 2032
- Table 150: Global Montelukast Sodium Market Volume K Unit Forecast, by Application 2019 & 2032
- Table 151: Global Montelukast Sodium Market Revenue Million Forecast, by Country 2019 & 2032
- Table 152: Global Montelukast Sodium Market Volume K Unit Forecast, by Country 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Montelukast Sodium Market?
The projected CAGR is approximately 12.60%.
2. Which companies are prominent players in the Montelukast Sodium Market?
Key companies in the market include Sanyo Chemical Industries Ltd, Merck & Co Inc, SK Capital (Apotex Inc), Sanofi Aventis SA, Morepen Laboratories, Teva Pharmaceuticals USA Inc, Delmar Chemicals Inc , Cipla Limited, SUN PHARMA, Intas Pharmaceuticals Ltd.
3. What are the main segments of the Montelukast Sodium Market?
The market segments include Dosage Form, Application.
4. Can you provide details about the market size?
The market size is estimated to be USD 4.08 Million as of 2022.
5. What are some drivers contributing to market growth?
Increasing Prevalence of Disease like Asthma. Allergic Rhinitis. etc.; Rise in Geriatric Population.
6. What are the notable trends driving market growth?
Asthma Segment is Expected to be Hold Significant Share in the Montelukast Sodium Market.
7. Are there any restraints impacting market growth?
Side Effects of the Product.
8. Can you provide examples of recent developments in the market?
In December 2021, Drug firm Morepen Laboratories received approval from the United States health regulator to market its generic anti-allergy drug (Fexofenadine Hydrochloride) in the American market.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million and volume, measured in K Unit.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Montelukast Sodium Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Montelukast Sodium Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Montelukast Sodium Market?
To stay informed about further developments, trends, and reports in the Montelukast Sodium Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence